The prolongation of reserpine-induced cardiac norepinephrine depletion by metabolic inhibitors.
D000313:Adrenal Medulla / Q000378:metabolism; D000577:Amides / Q000494:pharmacology; D000818:Animals; D003609:Dactinomycin / Q000494:pharmacology; D003864:Depression, Chemical; D004357:Drug Synergism; D006321:Heart / Q000187:drug effects; D066298:In Vitro Techniques; D008099:Liver / Q000378:metabolism; D008297:Male; D009206:Myocardium / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism*; D010477:Perfusion; D010634:Phenobarbital / Q000494:pharmacology; D011335:Proadifen / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000378:metabolism / Q000494:pharmacology*; D013438:Sulfhydryl Compounds / Q000494:pharmacology; D014316:Tritium
D000577:Amides; D013438:Sulfhydryl Compounds; D014316:Tritium; D003609:Dactinomycin; D012110:Reserpine; D011335:Proadifen; D009638:Norepinephrine; D010634:Phenobarbital